IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jo, Sungsin | - |
dc.contributor.author | Wang, Sung Eun | - |
dc.contributor.author | Lee, Young Lim | - |
dc.contributor.author | Kang, Suman | - |
dc.contributor.author | Lee, Bitnara | - |
dc.contributor.author | Han, Jinil | - |
dc.contributor.author | Sung, Il-Hoon | - |
dc.contributor.author | Park, Ye-Soo | - |
dc.contributor.author | Bae, Sang-Cheol | - |
dc.contributor.author | Kim, Tae-Hwan | - |
dc.date.accessioned | 2021-07-30T05:07:09Z | - |
dc.date.available | 2021-07-30T05:07:09Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2018-06 | - |
dc.identifier.issn | 1478-6354 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3104 | - |
dc.description.abstract | Background IL-17A has recently emerged as a potential target that regulates the extensive inflammation and abnormal bone formation observed in ankylosing spondylitis (AS). Blocking IL-17A is expected to inhibit bony ankylosis. Here, we investigated the effects of anti IL-17A agents in AS. Methods TNFα, IL-17A, and IL-12/23 p40 levels in serum and synovial fluid from patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA), osteoarthritis (OA), or healthy controls (HC) were measured by ELISA. Bone tissue samples were obtained at surgery from the facet joints of ten patients with AS and ten control (Ct) patients with noninflammatory spinal disease. The functional relevance of IL-17A, biological blockades, Janus kinase 2 (JAK2), and non-receptor tyrosine kinase was assessed in vitro with primary bone-derived cells (BdCs) and serum from patients with AS. Results Basal levels of IL-17A and IL-12/23 p40 in body fluids were elevated in patients with AS. JAK2 was also highly expressed in bone tissue and primary BdCs from patients with AS. Furthermore, addition of exogenous IL-17A to primary Ct-BdCs promoted the osteogenic stimulus-induced increase in ALP activity and mineralization. Intriguingly, blocking IL-17A with serum from patients with AS attenuated ALP activity and mineralization in both Ct and AS-BdCs by inhibiting JAK2 phosphorylation and downregulating osteoblast-involved genes. Moreover, JAK2 inhibitors effectively reduced JAK2-driven ALP activity and JAK2-mediated events. Conclusions Our findings indicate that IL-17A regulates osteoblast activity and differentiation via JAK2/STAT3 signaling. They shed light on AS pathogenesis and suggest new rational therapies for clinical AS ankylosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BIOMED CENTRAL LTD | - |
dc.title | IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sung, Il-Hoon | - |
dc.contributor.affiliatedAuthor | Park, Ye-Soo | - |
dc.contributor.affiliatedAuthor | Bae, Sang-Cheol | - |
dc.contributor.affiliatedAuthor | Kim, Tae-Hwan | - |
dc.identifier.doi | 10.1186/s13075-018-1582-3 | - |
dc.identifier.scopusid | 2-s2.0-85048144099 | - |
dc.identifier.wosid | 000434457300003 | - |
dc.identifier.bibliographicCitation | ARTHRITIS RESEARCH & THERAPY, v.20, pp.1 - 10 | - |
dc.relation.isPartOf | ARTHRITIS RESEARCH & THERAPY | - |
dc.citation.title | ARTHRITIS RESEARCH & THERAPY | - |
dc.citation.volume | 20 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | RADIOGRAPHIC PROGRESSION | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS | - |
dc.subject.keywordPlus | DISEASE-ACTIVITY | - |
dc.subject.keywordPlus | BONE-FORMATION | - |
dc.subject.keywordPlus | CRITERIA | - |
dc.subject.keywordPlus | SPONDYLOARTHRITIS | - |
dc.subject.keywordPlus | INTERLEUKIN-17A | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | SECUKINUMAB | - |
dc.subject.keywordAuthor | Ankylosing spondylitis | - |
dc.subject.keywordAuthor | Osteoblastic activity and differentiation | - |
dc.subject.keywordAuthor | IL-17A | - |
dc.subject.keywordAuthor | JAK2/STAT3 signaling | - |
dc.identifier.url | https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1582-3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.